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Introduction: Chemical Exchange Saturation Transfer (CEST) is a molecular imaging technique that allows indirect detection of protons associated with mobile
proteins. Recently a CEST application called glycoCEST has been used to detect glycogen content in vivo (Jones CJ, et al PNAS 2008). With glycoCEST, the -OH protons
of glycogen are saturated, transfer the saturation to bulk water by way of chemical exchange which reduces the bulk water signal in proportion to the glycogen
content. Because the –OH protons resonate 0.75 – 1.25 ppm downfield of water, a plot of the saturation effect vs. the offset frequency of the saturating RF field (the
z-spectrum) is asymmetric.
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Using glycoCEST to measure glycogen content may provide several advantages to conventional approaches (e.g. C MRS or percutaneous biopsy), including
improved temporal and spatial resolution; more widespread availability of the necessary equipment; and the ability to measure glycogen in multiple muscles
simultaneously. A potential challenge in glycoCEST imaging is the relatively small chemical shift difference between the OH protons and the bulk water resonance. In
this case a CEST effect may not be easily determined from the z-spectrum due to direct saturation of the water resonance (Smith SA, et al MRM 2009). However, at
ultra-high fields such as 7T, the spectral resolution between the glycogen OH protons and the bulk water protons is larger, which facilitates an easier detction of the
glycogen driven CEST effect. The larger chemical shift difference, coupled with the improved signal-to-noise ratio at high field, makes 7T a logical choice for glycoCEST
imaging. Therefore the purpose of this study was to determine the feasibility of glycoCEST imaging in human skeletal muscle in vivo at 7T. Further, we compared the
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asymmetry in the CEST spectrum due to glycogen, glycoCESTMTRasym, to C MRS measures of muscle glycogen, currently the gold standard for determining glycogen
content in vivo.
Methods: All studies were approved by the institutional review board, and signed, informed consent was obtained prior to study. Five apparently healthy subjects
(4 male; age 21-38 years) participated in the study. The subjects had varying physical activity patterns ranging from sedentary (<30 mins. of regular physical
activity/week) to very active (>60-90 mins. of physical activity/ day, 6-7 days/week). MR data were acquired using a Philips 7T Achieva whole-body human scanner.
Imaging data were acquired using a single-channel T/R extremity coil. Anatomical images (multi-shot, turbo-spin echo (TSE) TSE factor 3, TR/TE 622/13, 16 cm FOV,
reconstructed to 512 x 512) were acquired from the leg and used to locate the largest cross section of the calf. Single slice glycoCEST images (TR/TE 75/2.3, 20 cm
FOV, B1 = 3.5 μT, pulse duration 500 ms, at 41 RF offsets between ±2000 Hz plus image an RF offsets of ±80000 Hz) were acquired from the largest cross section of the
calf. Regions of interest (ROI) were manually drawn from the medial gastrocnemius (MG) using the high-resolution anatomical images as a guide. The magnitude of
the CEST effect was quantified by measuring the asymmetry in the z-spectrum as:

S (− Δω ) − S (Δω )
So
where S(Δω) is the signal S as a function of offset frequency (ω) and S0 is the mean S in the ±80,000 Hz offset images. glycoCESTMTRasym was characterized as the
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integral of the z-spectrum within the limits 0.75-1.25 ppm (ref). C spectra were acquired from the human calf muscles and a glycogen phantom with a C/ H partial
volume T/R coil. The glycogen phantom contained 150 mM (glucose units, oyster glycogen, Sigma-Aldrich) and sodium chloride to mimic loading of the coil by the
leg. Time domain data were acquired with a pulse-acquire routine using a block RF pulse (TR/TE 425/1.15, flip angle 70°, spectral band-width 16000, 1024 samples,
1600 NEx). The data were zero-filled to 8192 points, broadened with a 10Hz exponential filter, Fourier transformed, phased, and analyzed using commercially available
NMR analysis software (Acorn, Nuts Inc.). The muscle glycogen C-1 resonance was iteratively fit to a Lorentzian line-shape and the area of the peak was expressed
relative to the area of the
corresponding peak from the phantom.
The relationship between the
integrated glycoCESTMTRasym was
13
correlated to C MRS measures of
muscle glycogen using a Spearman’s
correlation coefficient.
GlycoCESTMTRasym (Δω ) =

Results and Discussion: Figure 1
Fig.1: Results from GlycoCEST of skeletal muscle at 7T. A) T1-weighted anatomical image, B) reference image for
shows the results from the glycoCEST
glycogen resonance (1.0 ppm), C) normalized image for glycogen resonance (-1.0 ppm), D) shift map calculated from
of skeletal muscle at 7T. Figure 2A
polynomial fit with color scale in Hz, and E) asymmetry map for glycogen (1.0 ppm).
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shows a sample in vivo C spectrum. A
significant glycoCEST effect is apparent
by comparing the reference image at 1 ppm (Fig. 1B) to glycogen –OH sensitive image at -1.0ppm (Fig. 1C). In addition, a glycoCEST effect was apparent in all subjects
2
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(Fig. 2B). Linear regression showed a strong (R = 0.64) association between the C MRS measurement of muscle glycogen and the glycoCESTMTRasym integral.
Conclusion These data, although preliminary, suggest that glycoCEST imaging at 7T can be used to image muscle glycogen in vivo.

Fig.2 A Sample C-1 glycogen resonance acquired from the leg. B) is the normalized z-spectrum and MTRasym for all 5 subjects. C) shows the relationship
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between C MRS measures of muscle glycogen and the integration of the MTRasym from 0.75 – 1.25 ppm.
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